NASDAQ: AMRNAmarin Corp PLC Stock Ownership - Who owns Amarin?
Insider buying vs selling
Have Amarin Corp PLC insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Peter L. Fishman | CFO;SVP | 2026-08-01 | 155 | $14.26 | $2.21kSell |
| Jonathan Provoost | CLO;EVP | 2026-07-01 | 1,264 | $15.94 | $20.15kSell |
| Peter L. Fishman | CFO;SVP | 2026-07-01 | 1,206 | $15.94 | $19.22kSell |
| David Paul Keenan | COO;EVP | 2026-07-01 | 1,926 | $15.94 | $30.70kSell |
| Steven B. Ketchum | CSci;EVP | 2026-07-01 | 1,887 | $15.94 | $30.08kSell |
| Aaron Berg | President and CEO | 2026-06-26 | 3,197 | $16.35 | $52.27kSell |
| Paul Cohen | Director | 2026-04-18 | 403 | $14.98 | $6.04kSell |
| Patrice Eadon Bonfiglio | Director | 2026-04-18 | 403 | $14.98 | $6.04kSell |
| Oliver Oconnor | Director | 2026-04-18 | 438 | $14.98 | $6.56kSell |
| Kostas D. Odysseas | Director | 2026-04-18 | 403 | $14.98 | $6.04kSell |
AMRN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AMRN insiders and whales buy or sell their stock.
AMRN Shareholders
What type of owners hold Amarin Corp PLC stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| James Healy | 4.48% | 18,924,976 | $260.22M | Insider |
| Abingworth LLP | 4.40% | 18,599,168 | $255.74M | Insider |
| Sofinnova Venture Partners VII L P | 2.02% | 8,513,388 | $117.06M | Insider |
| Southpoint Capital Advisors LP | 1.94% | 8,216,329 | $112.97M | Insider |
| Michael Torok | 1.15% | 4,850,000 | $66.69M | Insider |
| John F. Thero | 0.77% | 3,252,752 | $44.73M | Insider |
| Fountain Healthcare Partners Ltd | 0.60% | 2,534,782 | $34.85M | Insider |
| Michael Wayne Kalb | 0.08% | 337,314 | $4.64M | Insider |
| Joseph T. Kennedy | 0.08% | 317,860 | $4.37M | Insider |
| Patrick Holt | 0.07% | 314,426 | $4.32M | Insider |
AMRN vs General Drug Manufacturer Stocks
Amarin Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.